Search Results

Keyvan Sedaghat discussing how GPCR function is shaped by lipid raft compartmentalization, the expanding therapeutic efficacy and diagnostic innovation What the functional diversity of bitter taste receptors means for novel therapeutic

the company's ability to predict the residence time of a ligand and its potential correlation with a therapeutic Therapeutic Effect and Receptor Interactions Aurelien Rizk and Yamina had a detailed discussion about the importance of gaining more information about the therapeutic effect in patients or animals and the They also shared their preference for small molecule therapies over protein therapeutics.

Biology: The Role of Fluorescent Ligands in GPCR Research GPCRs are one of the most important families of therapeutic Celtarys’ cutting-edge fluorescent ligand technology and accelerate the development of GPCR-targeted therapeutics accelerate the adoption of our chemical tools and foster collaborations that turn receptor biology into therapeutic

Saraf " My research focuses on evaluating and targeting serotonin 1A receptors for therapeutic outcomes

Terry Hébert is a Professor within the Department of Pharmacology & Therapeutics at McGill University

biosensors, cryo-EM, photoswitchable ligands, and nanobodies as pharmacological tools and potential therapeutic

Introduction Drug discovery pipelines increasingly depend on screening platforms designed to identify therapeutically

His work carries direct translational relevance to diabetes and obesity therapeutics. opportunities for scientists and biotech leaders working across pharmacology, translational research, and therapeutic

Demet's research on the gain domain of adhesion GPCRs started during his postdoctoral studies and continued

She has advanced the use of computational methods to meet the challenges of designing therapeutics with

As a co-founder of Heptares Therapeutics , now called Sosei Heptares , a GPCR-focused drug discovery

Andrew Charles that who specialized in animal models of migraine and delta-opioid receptors as a therapeutic

orphan GPCRs from ‘locked’, inaccessible receptors to well-characterized and understood ‘unlocked’ therapeutic

record as a biologics leader as he led teams to discover and develop novel first-in-class antibody therapeutics

His recently published book on signaling bias, Biased Signaling in Physiology, Pharmacology, and Therapeutics

His recently published book on signaling bias, Biased Signaling in Physiology, Pharmacology, and Therapeutics

vehicle by which Andrew is translating fundamental findings to commercial products is Keltic Pharma Therapeutics

GPCR name (including misspells and variations) as a sub-domain or sub-folder.

Institute of Medical Research, Deputy Director of the Australian Research Council Centre for Personalised Therapeutics

Brian Collier in the Department of Pharmacology and Therapeutics at McGill University (1994).

The ultimate goal of Adriano’s research is to target novel aspects of GPCR signaling for therapeutic

Brian Collier in the Department of Pharmacology and Therapeutics at McGill University (1994).

nanobodies as research tools, to investigate different GPCR conformations, while also focusing on their therapeutic

Yamina will schedule a future talk with Jacek about GPCRs as therapeutic modalities. The discussion revealed their interest in GPCRs as therapeutic modalities and possible future collaborations

protein-coupled receptors (GPCRs) regulate motivated behavior and how these receptors can be targeted for therapeutic distinct signaling pathways with their physiological effects and may serve as the basis for more selective therapeutics

Michael Feigin is an Associate Professor in the Department of Pharmacology and Therapeutics, and Director of Graduate Studies of Experimental Therapeutics at Roswell Park Comprehensive Cancer Center in Buffalo disrupting histone processing on rapidly proliferating cells, such as cancer cells, and suggested a therapeutic

receptors would be a significant breakthrough in cardiovascular biology as they could be targeted for therapeutic

neuronal circuits — insights that inform next-generation functional assay development and translational therapeutic

of Canada (2014), the Julie Axelrod award from the American Society of Pharmacology and Exerimental Therapeutics

GPCRs in the regulation of physiologic/pathologic function in the heart in an effort to uncover novel therapeutic